Alessandro Arduini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alessandro Arduini has a total of 191 co-authors. Here are the top co-authors by number of shared publications:
Juan Sastre
Department of Physiology, Faculty of Pharmacy, University of Valencia, Valencia, Spain
13 shared publications- Javier Escobar
Sabartech S.L., Science Park of the University of Valencia, 46980 Paterna, Spain
11 shared publications - Máximo Vento
Neonatal Research Group, Health Research Institute La Fe (IISLAFE), Valencia, Spain
9 shared publications - Patrick Thomas Ellinor
Massachusetts General Hospital
6 shared publications Raquel Escrig
Division of Neonatology, University and Polytechnic Hospital La Fe, Valencia, Spain
6 shared publications- Javier Pereda
Department of Physiology, Faculty of Pharmacy, University of Valencia, 46100 Burjassot, Spain
5 shared publications
Latest Publications
- Top Cited Papers
- 7 August 2023
- Published by Springer Nature in Nature Methods
- Vol. 20 (9) , 1323-1335
Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender
Droplet-based single-cell assays, including single-cell RNA sequencing (scRNA-seq), single-nucleus RNA sequencing (snRNA-seq) and cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq), generate considerable background noise counts, the hallmark of which is nonzero counts in cell-free droplets and off-target gene expression in unexpected cell types. Such systematic background noise can lead to batch effects and spurious differential gene expression results. Here we develop a deep generative model based on the phenomenology of noise generation in droplet-based assays. The proposed model accurately distinguishes cell-containing droplets from cell-free droplets, learns the background noise profile and provides noise-free quantification in an end-to-end fashion. We implement this approach in the scalable and robust open-source software package CellBender. Analysis of simulated data demonstrates that CellBender operates near the theoretically optimal denoising limit. Extensive evaluations using real datasets and experimental benchmarks highlight enhanced concordance between droplet-based single-cell data and established gene expression patterns, while the learned background noise profile provides evidence of degraded or uncaptured cell types.
- 7 August 2023
- Published by Springer Nature in Nature Methods
- Vol. 20 (9) , 1323-1335
Top Cited PapersUnsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender
Droplet-based single-cell assays, including single-cell RNA sequencing (scRNA-seq), single-nucleus RNA sequencing (snRNA-seq) and cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq), generate considerable background noise counts, the hallmark of which is nonzero counts in cell-free droplets and off-target gene expression in unexpected cell types. Such systematic background noise can lead to batch effects and spurious differential gene expression results. Here we develop a deep generative model based on the phenomenology of noise generation in droplet-based assays. The proposed model accurately distinguishes cell-containing droplets from cell-free droplets, learns the background noise profile and provides noise-free quantification in an end-to-end fashion. We implement this approach in the scalable and robust open-source software package CellBender. Analysis of simulated data demonstrates that CellBender operates near the theoretically optimal denoising limit. Extensive evaluations using real datasets and experimental benchmarks highlight enhanced concordance between droplet-based single-cell data and established gene expression patterns, while the learned background noise profile provides evidence of degraded or uncaptured cell types.
- Top Cited Papers
- 22 June 2022
- Published by Springer Nature in Nature
- Vol. 608 (7921) , 174-180
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy
Heart failure encompasses a heterogeneous set of clinical features that converge on impaired cardiac contractile function1,2 and presents a growing public health concern. Previous work has highlighted changes in both transcription and protein expression in failing hearts3,4, but may overlook molecular changes in less prevalent cell types. Here we identify extensive molecular alterations in failing hearts at single-cell resolution by performing single-nucleus RNA sequencing of nearly 600,000 nuclei in left ventricle samples from 11 hearts with dilated cardiomyopathy and 15 hearts with hypertrophic cardiomyopathy as well as 16 non-failing hearts. The transcriptional profiles of dilated or hypertrophic cardiomyopathy hearts broadly converged at the tissue and cell-type level. Further, a subset of hearts from patients with cardiomyopathy harbour a unique population of activated fibroblasts that is almost entirely absent from non-failing samples. We performed a CRISPR-knockout screen in primary human cardiac fibroblasts to evaluate this fibrotic cell state transition; knockout of genes associated with fibroblast transition resulted in a reduction of myofibroblast cell-state transition upon TGFβ1 stimulation for a subset of genes. Our results provide insights into the transcriptional diversity of the human heart in health and disease as well as new potential therapeutic targets and biomarkers for heart failure.
- 22 June 2022
- Published by Springer Nature in Nature
- Vol. 608 (7921) , 174-180
Top Cited PapersSingle-nucleus profiling of human dilated and hypertrophic cardiomyopathy
Heart failure encompasses a heterogeneous set of clinical features that converge on impaired cardiac contractile function1,2 and presents a growing public health concern. Previous work has highlighted changes in both transcription and protein expression in failing hearts3,4, but may overlook molecular changes in less prevalent cell types. Here we identify extensive molecular alterations in failing hearts at single-cell resolution by performing single-nucleus RNA sequencing of nearly 600,000 nuclei in left ventricle samples from 11 hearts with dilated cardiomyopathy and 15 hearts with hypertrophic cardiomyopathy as well as 16 non-failing hearts. The transcriptional profiles of dilated or hypertrophic cardiomyopathy hearts broadly converged at the tissue and cell-type level. Further, a subset of hearts from patients with cardiomyopathy harbour a unique population of activated fibroblasts that is almost entirely absent from non-failing samples. We performed a CRISPR-knockout screen in primary human cardiac fibroblasts to evaluate this fibrotic cell state transition; knockout of genes associated with fibroblast transition resulted in a reduction of myofibroblast cell-state transition upon TGFβ1 stimulation for a subset of genes. Our results provide insights into the transcriptional diversity of the human heart in health and disease as well as new potential therapeutic targets and biomarkers for heart failure.
- Open Access
- 11 March 2022
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 21 (4) , 100223
TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery Disease
- 11 March 2022
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 21 (4) , 100223
Open AccessTAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery Disease
- Open Access
Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 mediated myocarditis
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection of host cells occurs predominantly via binding of the viral surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. 1 Hypertension and pre-existing cardiovascular disease are risk factors for morbidity from COVID-19, 2 and it remains uncertain whether the use of angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) impacts infection and disease. Here, we aim to shed light on this question by assessing ACE2 expression in normal and diseased human myocardial samples profiled by bulk and single nucleus RNA-seq.
Open AccessMyocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 mediated myocarditis
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection of host cells occurs predominantly via binding of the viral surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor. 1 Hypertension and pre-existing cardiovascular disease are risk factors for morbidity from COVID-19, 2 and it remains uncertain whether the use of angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) impacts infection and disease. Here, we aim to shed light on this question by assessing ACE2 expression in normal and diseased human myocardial samples profiled by bulk and single nucleus RNA-seq.
- Open Access
- 7 January 2020
- Published by Cold Spring Harbor Laboratory in bioRxiv
Transcriptional and Cellular Diversity of the Human Heart
Introduction: The human heart requires a complex ensemble of specialized cell types to perform its essential function. A greater knowledge of the intricate cellular milieu of the heart is critical to increase our understanding of cardiac homeostasis and pathology. As recent advances in low input RNA-sequencing have allowed definitions of cellular transcriptomes at single cell resolution at scale, here we have applied these approaches to assess the cellular and transcriptional diversity of the non-failing human heart.Methods: Microfluidic encapsulation and barcoding was used to perform single nuclear RNA sequencing with samples from seven human donors, selected for their absence of overt cardiac disease. Individual nuclear transcriptomes were then clustered based upon transcriptional profiles of highly variable genes. These clusters were used as the basis for between-chamber and between-sex differential gene expression analyses and intersection with genetic and pharmacologic dataResults: We sequenced the transcriptomes of 287,269 single cardiac nuclei, revealing a total of 9 major cell types and 20 subclusters of cell types within the human heart. Cellular subclasses include two distinct groups of resident macrophages, four endothelial subtypes, and two fibroblasts subsets. Comparisons of cellular transcriptomes by cardiac chamber or sex reveal diversity not only in cardiomyocyte transcriptional programs, but also in subtypes involved in extracellular matrix remodeling and vascularization. Using genetic association data, we identified strong enrichment for the role of cell subtypes in cardiac traits and diseases. Finally, intersection of our dataset with genes on cardiac clinical testing panels and the druggable genome reveals striking patterns of cellular specificity.Conclusions: Using large-scale single nuclei RNA sequencing, we have defined the transcriptional and cellular diversity in the normal human heart. Our identification of discrete cell subtypes and differentially expressed genes within the heart will ultimately facilitate the development of new therapeutics for cardiovascular diseases.
- 7 January 2020
- Published by Cold Spring Harbor Laboratory in bioRxiv
Open AccessTranscriptional and Cellular Diversity of the Human Heart
Introduction: The human heart requires a complex ensemble of specialized cell types to perform its essential function. A greater knowledge of the intricate cellular milieu of the heart is critical to increase our understanding of cardiac homeostasis and pathology. As recent advances in low input RNA-sequencing have allowed definitions of cellular transcriptomes at single cell resolution at scale, here we have applied these approaches to assess the cellular and transcriptional diversity of the non-failing human heart.Methods: Microfluidic encapsulation and barcoding was used to perform single nuclear RNA sequencing with samples from seven human donors, selected for their absence of overt cardiac disease. Individual nuclear transcriptomes were then clustered based upon transcriptional profiles of highly variable genes. These clusters were used as the basis for between-chamber and between-sex differential gene expression analyses and intersection with genetic and pharmacologic dataResults: We sequenced the transcriptomes of 287,269 single cardiac nuclei, revealing a total of 9 major cell types and 20 subclusters of cell types within the human heart. Cellular subclasses include two distinct groups of resident macrophages, four endothelial subtypes, and two fibroblasts subsets. Comparisons of cellular transcriptomes by cardiac chamber or sex reveal diversity not only in cardiomyocyte transcriptional programs, but also in subtypes involved in extracellular matrix remodeling and vascularization. Using genetic association data, we identified strong enrichment for the role of cell subtypes in cardiac traits and diseases. Finally, intersection of our dataset with genes on cardiac clinical testing panels and the druggable genome reveals striking patterns of cellular specificity.Conclusions: Using large-scale single nuclei RNA sequencing, we have defined the transcriptional and cellular diversity in the normal human heart. Our identification of discrete cell subtypes and differentially expressed genes within the heart will ultimately facilitate the development of new therapeutics for cardiovascular diseases.
- Open Access
Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender
Droplet-based single-cell assays, including scRNA-seq, snRNA-seq, and CITE-seq, produce a significant amount of background noise counts, the hallmark of which is non-zero counts in cell-free droplets and off-target gene expression in unexpected cell types. The presence of such systematic background noise is a potential source of batch effect and spurious differential gene expression. Here we develop a deep generative model for noise-contaminated data that is structured to reflect the phenomenology of background noise generation in droplet-based single-cell assays. The proposed model successfully distinguishes cell-containing from cell-free droplets without supervision, learns the profile of background noise, and retrieves a noise-free quantification in an end-to-end fashion. We present a scalable and robust implementation of our method as a module in the open-source software package CellBender . We show that CellBender operates close to the theoretically optimal denoising limit in simulated datasets, and present extensive evaluations using real datasets and experimental benchmarks drawn from different tissues, protocols, and modalities to show that CellBender significantly improves the agreement of droplet-based single-cell data with established gene expression patterns, and that the learned background noise profile provides evidence for degraded or uncaptured cell types.
Open AccessUnsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender
Droplet-based single-cell assays, including scRNA-seq, snRNA-seq, and CITE-seq, produce a significant amount of background noise counts, the hallmark of which is non-zero counts in cell-free droplets and off-target gene expression in unexpected cell types. The presence of such systematic background noise is a potential source of batch effect and spurious differential gene expression. Here we develop a deep generative model for noise-contaminated data that is structured to reflect the phenomenology of background noise generation in droplet-based single-cell assays. The proposed model successfully distinguishes cell-containing from cell-free droplets without supervision, learns the profile of background noise, and retrieves a noise-free quantification in an end-to-end fashion. We present a scalable and robust implementation of our method as a module in the open-source software package CellBender . We show that CellBender operates close to the theoretically optimal denoising limit in simulated datasets, and present extensive evaluations using real datasets and experimental benchmarks drawn from different tissues, protocols, and modalities to show that CellBender significantly improves the agreement of droplet-based single-cell data with established gene expression patterns, and that the learned background noise profile provides evidence for degraded or uncaptured cell types.
- Open Access
- 2 November 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (21)
Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5–dependent and –independent mechanisms
Hypertriglyceridemia is an independent risk factor for cardiovascular disease. Dietary interventions based on protein restriction (PR) reduce circulating triglycerides (TGs), but underlying mechanisms and clinical relevance remain unclear. Here, we show that 1 week of a protein-free diet without enforced calorie restriction significantly lowered circulating TGs in both lean and diet-induced obese mice. Mechanistically, the TG-lowering effect of PR was due, in part, to changes in very low–density lipoprotein (VLDL) metabolism both in liver and peripheral tissues. In the periphery, PR stimulated VLDL-TG consumption by increasing VLDL-bound APOA5 expression and promoting VLDL-TG hydrolysis and clearance from circulation. The PR-mediated increase in Apoa5 expression was controlled by the transcription factor CREBH, which coordinately regulated hepatic expression of fatty acid oxidation–related genes, including Fgf21 and Ppara . The CREBH-APOA5 axis activation upon PR was intact in mice lacking the GCN2-dependent amino acid–sensing arm of the integrated stress response. However, constitutive hepatic activation of the amino acid–responsive kinase mTORC1 compromised CREBH activation, leading to blunted APOA5 expression and PR-recalcitrant hypertriglyceridemia. PR also contributed to hypotriglyceridemia by reducing the rate of VLDL-TG secretion, independently of activation of the CREBH-APOA5 axis. Finally, a randomized controlled clinical trial revealed that 4–6 weeks of reduced protein intake (7%–9% of calories) decreased VLDL particle number, increased VLDL-bound APOA5 expression, and lowered plasma TGs, consistent with mechanistic conservation of PR-mediated hypotriglyceridemia in humans with translational potential as a nutraceutical intervention for dyslipidemia.
- 2 November 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (21)
Open AccessDietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5–dependent and –independent mechanisms
Hypertriglyceridemia is an independent risk factor for cardiovascular disease. Dietary interventions based on protein restriction (PR) reduce circulating triglycerides (TGs), but underlying mechanisms and clinical relevance remain unclear. Here, we show that 1 week of a protein-free diet without enforced calorie restriction significantly lowered circulating TGs in both lean and diet-induced obese mice. Mechanistically, the TG-lowering effect of PR was due, in part, to changes in very low–density lipoprotein (VLDL) metabolism both in liver and peripheral tissues. In the periphery, PR stimulated VLDL-TG consumption by increasing VLDL-bound APOA5 expression and promoting VLDL-TG hydrolysis and clearance from circulation. The PR-mediated increase in Apoa5 expression was controlled by the transcription factor CREBH, which coordinately regulated hepatic expression of fatty acid oxidation–related genes, including Fgf21 and Ppara . The CREBH-APOA5 axis activation upon PR was intact in mice lacking the GCN2-dependent amino acid–sensing arm of the integrated stress response. However, constitutive hepatic activation of the amino acid–responsive kinase mTORC1 compromised CREBH activation, leading to blunted APOA5 expression and PR-recalcitrant hypertriglyceridemia. PR also contributed to hypotriglyceridemia by reducing the rate of VLDL-TG secretion, independently of activation of the CREBH-APOA5 axis. Finally, a randomized controlled clinical trial revealed that 4–6 weeks of reduced protein intake (7%–9% of calories) decreased VLDL particle number, increased VLDL-bound APOA5 expression, and lowered plasma TGs, consistent with mechanistic conservation of PR-mediated hypotriglyceridemia in humans with translational potential as a nutraceutical intervention for dyslipidemia.
- 1 October 2018
- Published by Wolters Kluwer Health in Journal of Strength & Conditioning Research
- Vol. 32 (10) , 2846-2852
An Eighteen-Minute Submaximal Exercise Test to Assess Cardiac Fitness in Response to Aerobic Training
We aimed to evaluate the utility of a submaximal heart rate recovery (HRR) test to monitor changes in cardiac fitness after aerobic training. Twenty healthy subjects were assigned to a control (n=10) or a training (n=10) group. Subjects in the training group performed 8 weeks of bicycle training, followed by 8 weeks of detraining. HRR was assessed after exercises at 65% and 80% HRmax. The HRR test was performed at weeks 0 (W0), 4 (W4), 8 (W8) and 16 (W16) in the training group and at W0 and W8 in the control group. HRR indices changed in response to training and detraining. Absolute HR recovery at 60, 120 and 180 seconds after exercise increased at both exercise intensities at W8 of training (p0.05, W16 vs. W0). Time constants of fast HRR recovery (<1 min) changed with training (p0.05, W16 vs. W0), but only at 65% HRmax. At the end of the 3-minute recovery period, the predicted HR value (A0) and the HR recovered (Amax) from the mono-exponential analysis changed with training (p0.05. W16 vs. W0). We conclude that this novel submaximal HRR test is highly sensitive for monitoring cardiac fitness during training and detraining in healthy people. Since this test is simple, inexpensive, and the data are reliable and easy to analyze, we hope that it may be of interest to the sports science community.
- 1 October 2018
- Published by Wolters Kluwer Health in Journal of Strength & Conditioning Research
- Vol. 32 (10) , 2846-2852
An Eighteen-Minute Submaximal Exercise Test to Assess Cardiac Fitness in Response to Aerobic Training
We aimed to evaluate the utility of a submaximal heart rate recovery (HRR) test to monitor changes in cardiac fitness after aerobic training. Twenty healthy subjects were assigned to a control (n=10) or a training (n=10) group. Subjects in the training group performed 8 weeks of bicycle training, followed by 8 weeks of detraining. HRR was assessed after exercises at 65% and 80% HRmax. The HRR test was performed at weeks 0 (W0), 4 (W4), 8 (W8) and 16 (W16) in the training group and at W0 and W8 in the control group. HRR indices changed in response to training and detraining. Absolute HR recovery at 60, 120 and 180 seconds after exercise increased at both exercise intensities at W8 of training (p0.05, W16 vs. W0). Time constants of fast HRR recovery (<1 min) changed with training (p0.05, W16 vs. W0), but only at 65% HRmax. At the end of the 3-minute recovery period, the predicted HR value (A0) and the HR recovered (Amax) from the mono-exponential analysis changed with training (p0.05. W16 vs. W0). We conclude that this novel submaximal HRR test is highly sensitive for monitoring cardiac fitness during training and detraining in healthy people. Since this test is simple, inexpensive, and the data are reliable and easy to analyze, we hope that it may be of interest to the sports science community.
- 31 July 2015
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 349 (6247) , 500-506
S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction
S-nitrosylation links obesity and cell stress: Obesity and other diseases are somehow linked to malfunction of the protein-protecting functions of the endoplasmic reticulum (ER). Yang et al. propose a mechanism by which obesity and associated chronic inflammation may be linked to the accumulation of unfolded proteins in the ER. Such stress would normally trigger the process known as the unfolded protein response (UPR). However, obese mice had increased S-nitrosylation of inositol-requiring protein-1 (IRE1α), a ribonuclease that regulates the UPR. The modified IRE1α had decreased RNAse activity. The authors expressed an IRE1α mutant protein that could not be nitrosylated in the liver of obese mice. This approach improved the UPR and helped restore glucose homeostasis. Science , this issue p. 500
- 31 July 2015
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 349 (6247) , 500-506
S-Nitrosylation links obesity-associated inflammation to endoplasmic reticulum dysfunction
S-nitrosylation links obesity and cell stress: Obesity and other diseases are somehow linked to malfunction of the protein-protecting functions of the endoplasmic reticulum (ER). Yang et al. propose a mechanism by which obesity and associated chronic inflammation may be linked to the accumulation of unfolded proteins in the ER. Such stress would normally trigger the process known as the unfolded protein response (UPR). However, obese mice had increased S-nitrosylation of inositol-requiring protein-1 (IRE1α), a ribonuclease that regulates the UPR. The modified IRE1α had decreased RNAse activity. The authors expressed an IRE1α mutant protein that could not be nitrosylated in the liver of obese mice. This approach improved the UPR and helped restore glucose homeostasis. Science , this issue p. 500
- 12 May 2014
- Published by Springer Nature in Pediatric Research
- Vol. 76 (2) , 127-134
Metabolic adaptation and neuroprotection differ in the retina and choroid in a piglet model of acute postnatal hypoxia
Hypoxic-ischemic insults to the neonatal brain may cause neurodevelopmental disorders. Vulnerability of different areas of the neural tissue to hypoxic-ischemic stress might be explained by either heterogeneous sensitivity to oxygen or neuroprotective capability. Our understanding of regional heterogeneity is still incomplete in terms of metabolic reconfiguration and/or activation of neuroprotective mechanisms. We studied, by western blotting, reverse-transcriptase PCR, and tandem mass spectrometry, the response of retina and choroid at protein, gene, and metabolic levels during hypoxia in a piglet model of acute postnatal hypoxia. We evidenced a metabolic shift towards glycolysis in choroid after hypoxia while retina experienced a dramatic energy stress with decreased mitochondrial metabolites. Hypoxia-inducible transcription factor-1α (HIF-1α) was not stabilized in retina during hypoxia, supported by a deficient signaling from v-akt murine thymoma viral oncogene (AKT) and ERK1/2, and unchanged glutathione redox status. In retina, but not in choroid, phosphorylation of p65 (NF-κB) and increased transcription of target genes may have a major role during hypoxic stress. We showed that the retina engages a distinct pattern of signaling and transcriptional events than observed in the choroid. Retina and choroid may reflect regional sensitivity to hypoxia. While prolonged and intense hypoxia may jeopardize retinal cell survival, choroid sets up a different pattern of response, which promotes adaptation to these adverse conditions.
- 12 May 2014
- Published by Springer Nature in Pediatric Research
- Vol. 76 (2) , 127-134
Metabolic adaptation and neuroprotection differ in the retina and choroid in a piglet model of acute postnatal hypoxia
Hypoxic-ischemic insults to the neonatal brain may cause neurodevelopmental disorders. Vulnerability of different areas of the neural tissue to hypoxic-ischemic stress might be explained by either heterogeneous sensitivity to oxygen or neuroprotective capability. Our understanding of regional heterogeneity is still incomplete in terms of metabolic reconfiguration and/or activation of neuroprotective mechanisms. We studied, by western blotting, reverse-transcriptase PCR, and tandem mass spectrometry, the response of retina and choroid at protein, gene, and metabolic levels during hypoxia in a piglet model of acute postnatal hypoxia. We evidenced a metabolic shift towards glycolysis in choroid after hypoxia while retina experienced a dramatic energy stress with decreased mitochondrial metabolites. Hypoxia-inducible transcription factor-1α (HIF-1α) was not stabilized in retina during hypoxia, supported by a deficient signaling from v-akt murine thymoma viral oncogene (AKT) and ERK1/2, and unchanged glutathione redox status. In retina, but not in choroid, phosphorylation of p65 (NF-κB) and increased transcription of target genes may have a major role during hypoxic stress. We showed that the retina engages a distinct pattern of signaling and transcriptional events than observed in the choroid. Retina and choroid may reflect regional sensitivity to hypoxia. While prolonged and intense hypoxia may jeopardize retinal cell survival, choroid sets up a different pattern of response, which promotes adaptation to these adverse conditions.